1 – 2 of 2
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.
(
- Contribution to journal › Article